According to Cognitive Market Research, the global Lenalidomide market size is USD 19584.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 5.50% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 7833.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 5875.35 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 4504.44 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
Latin America had a market share for more than 5% of the global revenue with a market size of USD 979.23 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 391.69 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
In 2023, the 15-mg segment had the most revenue share in the industry market
